Big changes in the pharmaceutical sector as leading brands flourish
A deep dive into key data about the pharmaceuticals sector suggests that over-regulation and availability of skills and technology remain key challenges; while the leading brands continue to rise in value, most are still filing in single classes only
Risks and opportunities are in abundance for brand owners in the sprawling, ever-changing pharmaceutical sector. This article breaks down how the sector is being affected by political and economic pressures and identifies the industry-specific developments that are driving change. It also analyses the performance of the leading brands in this space and identifies the most important markets for rights holders.
This part of the website has now moved to the subscriber area. To read more, please pick an option below.
Register to access two articles per month
Subscribe for unlimited access to articles, in-depth analysis and research from the World Trademark Review experts
What our customers are saying
“An excellent service – I look forward to the email every day”
Subscribe to World Trademark Review to receive access to the full range of trademark intelligence, insight, and case law, as well as our guides, rankings and daily market insight delivered to your inbox.